Moderna 's (NASDAQ: MRNA) wild success in the COVID-19 vaccine market has worn off. The company's revenue, earnings, and stock price have been moving in the wrong direction for the past three years, a...
A five-bagger in only five years? Any investor would love to buy such a stock. Fortunes can be made quickly with those kinds of turbocharged performers.
Wall Street closed lower on Tuesday, eagerly awaiting the Fed meeting. Market participants showed restraint in trading ahead of the Fed's last policy announcement of 2024 after economic data released on...
Investing in biotech stocks usually isn't for the faint of heart. These stocks tend to be highly volatile because of the inherent risks of developing new drugs.
U.S. stock indexes trimmed some of their stellar gains for the year
/Moderna%20Inc%20meds-by%20Ascannio%20via%20Shutterstock.jpg)
Moderna has significantly underperformed the Dow over the past year, and analysts are cautious about the stock’s prospects.
I love generating passive income. I currently use that income to make more income-generating investments. My goal is to eventually make enough income from passive sources to cover my routine living expenses....
Palantir stock's huge rise this year has earned it a spot on another stock index.
2024 has been a generally outstanding year for the stock market, with the S&P 500 (SNPINDEX: ^GSPC) up by nearly 30% year to date as of Dec. 11. However, not all stocks have performed nearly this well...
GSK GSK stock has declined 20.2% in the past three months compared with a decrease of 12.3% for the industry. The stock has also underperformed the sector and the S&P 500 index, as seen in the chart below....